SweetBodyLabs · Peptides · Performance

✦ 99.8% pure✦ research only✦ ships in 24h✦ third-party tested✦ free shipping over $99✦ 99.8% pure✦ research only✦ ships in 24h✦ third-party tested✦ free shipping over $99✦ 99.8% pure✦ research only✦ ships in 24h✦ third-party tested✦ free shipping over $99

RETTA

"Tri-receptor agonist. GLP-1, GIP, glucagon. The most ambitious metabolic protocol on the bench."

99% Purity

Spotlight Compound —

RETTA

Retatrutide · Triple Agonist

A next-generation tri-receptor agonist engineered for the most ambitious metabolic and body-composition research protocols on the bench today.

Metabolic Drive

Appetite Signaling

Lipolysis Research

Glycemic Control

Request lot data Research Use Only

★ HPLC verified★ LC-MS/MS confirmed★ sterile & sealed★ USA sourced★ bench-ready★ HPLC verified★ LC-MS/MS confirmed★ sterile & sealed★ USA sourced★ bench-ready★ HPLC verified★ LC-MS/MS confirmed★ sterile & sealed★ USA sourced★ bench-ready

Bold science. Strong results.

For the lab
that refuses
to settle.

We took the clinical data and wrapped it in candy-coated conviction. No filler. No fluff. Just the raw materials your research deserves — frost-sealed, lab-verified, and built for data that speaks for itself.

HPLCLC-MS/MSSterileUSA

Fan favorites —

Featured on the bench

🔥

Retatrutide

A next-gen triple agonist targeting GLP-1, GIP, and glucagon receptors simultaneously. Investigated for multi-pathway metabolic enhancement, energy expenditure, and advanced body-composition research.

💉

Tirzepatide

A dual GIP and GLP-1 receptor agonist studied for glucose homeostasis, appetite regulation, and body composition research. Shown in clinical models to enhance satiety signaling and improve metabolic markers.

⚡

Semaglutide

A potent GLP-1 receptor agonist widely researched for glycemic control, gastric emptying modulation, and appetite suppression. Key compound in metabolic and weight-management peptide studies.

View full catalog